Загрузка...
Chemically treated plasma Aβ is a potential blood-based biomarker for screening cerebral amyloid deposition
BACKGROUND: Plasma β-amyloid (Aβ) is a potential candidate for an Alzheimer’s disease (AD) biomarker because blood is an easily accessible bio-fluid, which can be collected routinely, and Aβ is one of the major hallmarks of AD pathogenesis in the brain. However, the association between plasma Aβ lev...
Сохранить в:
| Опубликовано в: : | Alzheimers Res Ther |
|---|---|
| Главные авторы: | , , , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5361707/ https://ncbi.nlm.nih.gov/pubmed/28330509 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-017-0248-8 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|